Lixte Biotechnology prices $4.3M registered direct offering
Source: SeekingAlpha
2025-12-18 10:30:15 ET
More on Lixte Biotechnology Holdings, Inc.
- Seeking Alpha’s Quant Rating on Lixte Biotechnology Holdings, Inc.
- Financial information for Lixte Biotechnology Holdings, Inc.
Read the full article on Seeking Alpha
For further details see:
Lixte Biotechnology prices $4.3M registered direct offering
Lixte Biotechnology Holdings Inc.
NASDAQ: LIXT
LIXT Trading
7.45% G/L:
$2.74 Last:
7,185 Volume:
$2.75 Open:
LIXT Latest News
March 09, 2026 12:05:00 pm
Building a New Cancer Care Ecosystem: Liora's Proton Therapy and LIXTE's Drug Pipeline in Synergy
March 06, 2026 03:16:16 pm
TinyGemsBreaks - LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline
March 06, 2026 09:50:00 am
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Research
LIXT Stock Data
$24,646,143
7,717,910
9.87%
4
N/A
Biotechnology & Life Sciences
Healthcare
US
Boca Raton
